ONO-9054   Click here for help

GtoPdb Ligand ID: 9875

Synonyms: sepetaprost
Compound class: Synthetic organic
Comment: Agonist at both the prostanoid FP and EP3 receptors that has clinical efficacy as an ocular hypotensive agent [1-2,4].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 11
Topological polar surface area 85.22
Molecular weight 482.25
XLogP 4.03
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(OC(=O)CCCC1CCC2C(OC1)CC(C2C=CC(COc1cc(F)ccc1F)O)O)C
Isomeric SMILES CC(OC(=O)CCC[C@H]1CC[C@H]2[C@@H](OC1)C[C@H]([C@@H]2/C=C/[C@H](COc1cc(F)ccc1F)O)O)C
InChI InChI=1S/C26H36F2O6/c1-16(2)34-26(31)5-3-4-17-6-9-21-20(23(30)13-24(21)32-14-17)10-8-19(29)15-33-25-12-18(27)7-11-22(25)28/h7-8,10-12,16-17,19-21,23-24,29-30H,3-6,9,13-15H2,1-2H3/b10-8+/t17-,19+,20+,21+,23+,24-/m0/s1
InChI Key BKVUSNOUTQMSBE-XCMGCKIWSA-N
References
1. Harris A, Ward CL, Rowe-Rendleman CL, Ouchi T, Wood A, Fujii A, Serle JB. (2016)
Ocular Hypotensive Effect of ONO-9054, an EP3/FP Receptor Agonist: Results of a Randomized, Placebo-controlled, Dose Escalation Study.
J Glaucoma, 25 (10): e826-e833. [PMID:27300645]
2. Klimko PG, Sharif NA. (2019)
Discovery, characterization and clinical utility of prostaglandin agonists for the treatment of glaucoma.
Br J Pharmacol, 176 (8): 1051-1058. [PMID:29665040]
3. Miller Ellis E, Berlin MS, Ward CL, Sharpe JA, Jamil A, Harris A. (2017)
Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study.
Br J Ophthalmol, 101 (6): 796-800. [PMID:27649982]
4. Yamane S, Karakawa T, Nakayama S, Nagai K, Moriyuki K, Neki S, Suto F, Kambe T, Hirota Y, Kawabata K. (2015)
IOP-Lowering Effect of ONO-9054, A Novel Dual Agonist of Prostanoid EP3 and FP Receptors, in Monkeys.
Invest Ophthalmol Vis Sci, 56 (4): 2547-52. [PMID:25788650]